Lipid Signaling Pathways in Drug Delivery and Therapeutics
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 4925
Special Issue Editor
Interests: polyunsaturated fatty acid metabolism; lipid signaling; bioorganic chemistry; medicinal chemistry; drug development; lipid mediator pharmacology; pharmacokinetic; assay development
Special Issue Information
Dear Colleagues,
Lipids, one of the basic building blocks of life, play a critical role in organismal physiology. Several classes of lipids and their downstream metabolites act as secondary messengers. These molecules interact with a variety of cellular targets including G-protein-coupled receptors, ion channels, nuclear receptors, kinases, etc. However, these endogenous lipids often have poor drug-like properties, since they are highly lipophilic with scarce water solubility, metabolically unstable, and poorly bioavailable. Therefore, it would be valuable to design novel molecules such as enzyme inhibitors that stabilize endogenous lipid mediators (e.g., ibuprofen) and mimics that act as agonists or antagonists of lipid signalling pathways. In addition, novel drug delivery systems could be developed to directly administer these specific molecules to target organs. In this Special Issue, we aim to present and discuss novel therapies targeting lipid signalling pathways.
Dr. Kin Sing Stephen Lee
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Lipid signalling molecules
- Enzyme inhibitors
- Agonist
- Antagonist
- Drug discovery and development
- Drug design
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.